未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏Morphological insights in oxidative sensitive nanocarrier pharmacokinetics, targeting, and photodynamic therapy
Ding, Haitao; Su, Liping; Xie, Zhendong; Castano, Aroa Duro; Li, Yunkun; Perez, Lorena Ruiz; Chen, Junyang; Luo, Kui; Tian, Xiaohe; Battaglia, Giuseppe
分享
收藏Super-enhancer Activates Master Transcription Factor NR3C1 Expression and Promotes 5-FU Resistance in Gastric Cancer超级增强子激活主转录因子NR3C1的表达并促进胃癌对5-FU的耐药性
Yu, JX; Chen, MD; Sang, QQ; Li, FY; Xu, ZQ; Yu, BQ; He, CY; Su, LP; Dai, WT; Yan, C; Zhu, ZG; Xia, JZ; Li, JF; Feng, HR; Chen, YQ; Li, YY; Liu, BY
分享
收藏
分享
收藏
分享
收藏SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancerSLC7A9抑制通过抑制胱氨酸转运诱导铁死亡增加胃癌的化学敏感性
Feng, Haoran; Yu, Junxian; Xu, Zhuoqing; Sang, Qingqing; Li, Fangyuan; Chen, Mengdi; Chen, Yunqin; Yu, Beiqin; Zhu, Nan; Xia, Jiazeng; He, Changyu; Hou, Junyi; Wu, Xiongyan; Yan, Chao; Zhu, Zhenggang; Su, Liping; Li, Jianfang; Dai, Wentao; Li, Yuan-Yuan; Liu, Bingya
分享
收藏Targeting CBP revers chemoresistance to 5-FU of CDX2/REG4 double-positive gastric cancer
Fan, Zhiyuan; Li, Fangyuan; Jiang, Xiao; Pan, Tao; Zang, Mingde; Li, Jianfang; Yu, Beiqin; Sang, Qingqing; Liu, Wentao; Su, Liping; Li, Chen; Zhu, Zhenggang; Yan, Min; Yan, Chao; Yuan, Fei; Liu, Bingya
分享
收藏
分享
收藏Comparison of efficacy and safety between glofitamab and real-world regimens among Chinese patients with 3L+relapsed/refractory diffuse large B-cell lymphoma: An external control study比较 glofitamab 与真实世界方案在中国 3L+ 复发/难治性弥漫性大 B 细胞淋巴瘤患者中的疗效和安全性:一项外部对照研究
Zhou, K.; Wu, H.; Zhao, X.; Tan, X.; Yan, X.; Liu, H.; Su, L.; Lan, Y.; Xu, J.; Zhou, X.; Shuang, Y.; Zhang, H.
分享
收藏
分享
收藏Dendritic nanomedicine enhances chemo-immunotherapy by disturbing metabolism of cancer-associated fibroblasts for deep penetration and activating function of immune cells
Li, Yunkun; Shen, Xiaoding; Ding, Haitao; Zhang, Yuxin; Pan, Dayi; Su, Liping; Wu, Yahui; Fang, Zaixiang; Zhou, Jie; Gong, Qiyong; Luo, Kui
分享
收藏Tislelizumab (Tisle) combined with POFI (irinotecan, paclitaxel, oxaliplatin and 5-FU/levoleucovorin) as first-line treatment of advanced gastric/gastroesophageal junction adenocarcinoma (AGC): Update from a single-arm, openlabel phase I/II trial (SYLT-023)
Lin, R.; Ye, Z.; Zhuo, C.; Wei, S.; Li, Z.; Zhao, S.; Su, L.
分享
收藏
分享
收藏
分享
收藏Ascorbic Acid Promotes Ventricular Myosin Light Chain-2 Protein Expression and Maturation of Human Induced Pluripotent Stem Cells Derived Cardiomyocytes
Gao, Yu; Su, Liping; Wei, Yuhua; Hu, Zhenyu; Tao, Zhonghao; Kovalik, Jean-Paul; Soong, Tuck Wah; Zhang, Jianyi J.; Pu, Jun; Ye, Lei
分享
收藏Androgen receptor promotes cell stemness via interacting with co-factor YAP1 in gastric cancer
Hou, Junyi; Pan, Tao; Li, Fangyuan; Sang, Qingqing; Wu, Xiongyan; Li, Jianfang; Yu, Beiqin; Zang, Mingde; Zhu, Zheng-gang; Su, Liping; Liu, Bingya
分享
收藏BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C-MYC/PLCG1/Perk AxisBPTF通过表观遗传调节c-myc/PLCG1/Perk轴驱动胃癌对EGFR抑制剂的耐药性
Li, Fangyuan; Yu, Junxian; Pan, Tao; Feng, Haoran; Li, Jianfang; Yu, Beiqin; Fan, Zhiyuan; Sang, Qingqing; Chen, Mengdi; Zang, Mingde; Hou, Junyi; Wu, Xiongyan; Yu, Yingyan; Li, Yuan-Yuan; Yan, Chao; Zhu, Zhenggang; Su, Liping; Liu, Bingya
分享
收藏